Silicosis: Treatment When Initial Therapies Have Not Achieved Adequate Control

This protocol addresses patients with silicosis who have progressed to end-category disease — those for whom first-line management did not produce sufficient improvement in symptoms, lung function, or radiological findings.

Prior Treatment & Failure Condition

Initial management — including large volume whole-lung lavage, tetrandrine, traditional Chinese medicines, and exercise training — was directed at improving chest tightness, chest pain, and shortness of breath, as well as pulmonary function and radiological appearance of the lungs. This protocol applies when those goals were not adequately reached and the disease has progressed to end-category severity.

Next-Step Approach (partial)

For end-category silicosis that has not responded to initial measures, management centres on a major surgical intervention for end-stage lung disease, combined with long-term systemic medical therapy.

The complete regimen — specific interventions, medications, sequencing, and follow-up considerations — is available in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

Lung transplantation is the main modality for the treatment of end-category silicosis, and it can help patients with end-category fibrosis to live longer.

In addition, long-term oral antirejection immunosuppressants are required.

DOI: 10.1155/2022/3769134

View source ↗